Journal Title：Pediatric Hematology And Oncology

PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.

PHO：兒科血液學和腫瘤學涵蓋了兒童血液疾病和惡性疾病領域研究和患者管理的所有方面。我們的目標是讓 PHO：兒科血液學和腫瘤學成為國際臨床醫(yī)生和科學家社區(qū)的頂級期刊，他們共同致力于為患有癌癥和血液疾病的兒童和年輕人制定最佳治療策略。該期刊支持涉及不同臨床環(huán)境中的研究的文章、為發(fā)病機制和/或臨床護理增加新見解的特殊案例研究/系列，以及強調聯(lián)盟和會議中出現(xiàn)的發(fā)現(xiàn)和挑戰(zhàn)的評論。臨床研究以及有關癌癥發(fā)病機制、遺傳學、分子診斷、藥理學、干細胞、分子靶向、細胞和免疫療法以及移植的基礎和轉化研究報告都很有趣。我們也歡迎關注支持性護理、后期影響以及這些領域相關的倫理、法律、心理、社會、文化或歷史方面的論文。歡迎對該領域重要發(fā)展的評論。考慮發(fā)表來自國際兒科血液學和腫瘤學界科學家和臨床醫(yī)生的文章。該期刊不依賴或與任何組織或協(xié)會有聯(lián)系。所有投稿在發(fā)表前都經過嚴格的同行評審。我們的編輯委員會包括代表廣泛學術和地域多樣性的兒科血液學和腫瘤學專家。

Pediatric Hematology And Oncology創(chuàng)刊于1986年，由Informa Healthcare出版商出版，收稿方向涵蓋醫(yī)學 - 小兒科全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業(yè)影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 較慢,6-12周 ，影響因子指數(shù)1.2，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。